Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
This meta-epidemiological study analyzes phase 3 oncology randomized clinical trials to determine the proportions of trials that show improvement in overall survival, quality of life, and alternative end points and compares these outcomes with overall trial interpretation.